Michael Arlotto Email & Phone

Chief Operating Officer @ Premier Research

Global Vice President, Corporate Development @ Quintiles Transnational Corp

Senior Vice President, NovaQuest @ Quintiles

Senior Vice President, Project Management, Clinical Development Services @ Quintiles

Vice President, Strategic Planning and Risk Management, Clinical Development Services @ Quintiles

Senior Director, Corporate Planning and Business Integration @ Quintiles

Senior VP Global Functions @ Premier Research

Managing Director @ Arlotto Strategic Services, LLC

Founder and CEO @ Remarque Systems

Director, Corporate Planning and Business Integration @ Quintiles

Senior Research Scientist @ Bayer Pharmaceuticals

Director, Scientific Planning and Development @ Dallas Biomedical Inc.

Board of Directors, GeneScreen Inc. @ Dallas Biomedical Inc.

Research Scientist, Oxygene Dallas Corp. @ Dallas Biomedical Inc.

Oak Ridge University Post-doctoral Fellow @ FDA

1983 - 1988 PhD @ University of Kansas School of Medicine

1979 - 1983 BS @ University of the Sciences in Philadelphia

Pharmaceutical Industry, Clinical Development, Biotechnology, Oncology, CRO, Clinical Trials, Lifesciences, Clinical Research, CTMS, Drug Development, GCP, Drug Discovery, Clinical Operations, Medical Devices, Therapeutic Areas, Technology Transfer, CRO Management, Biopharmaceuticals, Clinical Monitoring, Business Analysis, Management, Biochemistry, Molecular Biology, Process Improvement, Immunology, Clinical Trial Management System Ctms, Ich Gcp, Cardiology, GMP, Antibodies, Clinical Data Management, Commercialization, Drug Metabolism, Good Clinical Practice Gcp, Clinical Study Design, EDC, Cancer, Diabetes, GLP, Biomarkers, FDA, 21 CFR Part 11, IND, Laboratory, Medical Writing, Infectious Diseases, Neurology, Life Sciences, Pharmacovigilance, Protocol, Pharmaceutics, In Vitro, Pharmacology, Pharmacokinetics, Medical Affairs, Clinical Trial Management System, Good Clinical Practice

Michael Arlotto, based in Chapel Hill, NC, US, is currently a Chief Operating Officer at Premier Research. Michael Arlotto brings experience from previous roles at Quintiles Transnational Corp, Quintiles, Quintiles, Quintiles, Quintiles, Premier Research, Arlotto Strategic Services, LLC, Remarque Systems, Quintiles, Bayer Pharmaceuticals, Dallas Biomedical Inc., Dallas Biomedical Inc., Dallas Biomedical Inc., FDA. Michael Arlotto holds various educational qualifications including PhD in Toxicology (1983 - 1988) from University of Kansas School of Medicine. With a robust skill set that includes Pharmaceutical Industry, Clinical Development, Biotechnology, Oncology, CRO, Michael Arlotto demonstrates proficiency in a wide range of areas.